Results 241 to 250 of about 9,858,231 (365)
PROCEEDINGS OF THE THIRD NATIONAL CANCER CONFERENCE [PDF]
Alton Ochsner
openalex +1 more source
Tumor‐informed whole‐genome sequencing (MRD‐EDGESNV) was applied to detect circulating tumor DNA (ctDNA) in patients with colorectal adenomas. Using a 95% specificity threshold, established from stage III colorectal cancer patients, ctDNA was detected in 50% of symptomatic and 25% of asymptomatic adenoma cases with median tumor fractions of 5.9 × 10−5 ...
Amanda Frydendahl+13 more
wiley +1 more source
Gut microbiota, blood metabolites, & pan-cancer: a bidirectional Mendelian randomization & mediation analysis. [PDF]
Luan B+8 more
europepmc +1 more source
An Address ON CANCER: WITH DEMONSTRATION ON THE EPIDIASCOPE [PDF]
J. R. Morison
openalex +1 more source
Lehigh Valley Hospital: Statistical Report 2018 [PDF]
Lehigh Valley Health Network
core +1 more source
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source
Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation. [PDF]
Dodkins J+10 more
europepmc +1 more source
eHealth for Breast Cancer Survivors: Use, Feasibility and Impact of an Interactive Portal [PDF]
Aaronson, N.K.+5 more
core +1 more source
Clinical significance of stratifying prostate cancer patients through specific circulating genes
We tested a specific panel of genes representative of luminal, neuroendocrine and stem‐like cells in the blood of prostate cancer patients, showing predictive value from diagnosis to late stages of disease. This approach allows monitoring of treatment responses and outcomes at specific time points in trajectories.
Seta Derderian+12 more
wiley +1 more source